HighTower Advisors’s ENvue Medical Inc FEED Stock Holding History

HighTower Advisors’s Portfolio FEED Stock Details FEED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4	Closed	-$79K	–	3347
2021 Q2	$79K	Hold	4	–	–	﹤0.01%	2844
2021 Q1	$94K	Buy	4 +2	+100%	+$61.5K	﹤0.01%	2772
2020 Q4	$45K	Hold	2	–	–	﹤0.01%	2418
2020 Q3	$41K	Buy	+2	New	+$63.9K	﹤0.01%	2315

Other funds holding FEED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AFS

Amtrust Financial Services New York $336M AUM 16.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

HighTower Advisors's FEED Position: Q3 2021 in Review

HighTower Advisors sold out of ENvue Medical Inc (FEED) in Q3 2021, closing a stake of 4 shares — an estimated $79K sold.

HighTower Advisors first reported a position in FEED in Q3 2020 and held it in 4 quarters. The position peaked at $94K in Q1 2021. 15 funds tracked by Wall St. Rank hold FEED as of Q3 2021.

HighTower Advisors reported no remaining ENvue Medical Inc position as of Q3 2021 after selling out during the quarter.
HighTower Advisors sold 4 ENvue Medical Inc shares in Q3 2021, an estimated $79K.
HighTower Advisors first reported a position in ENvue Medical Inc in Q3 2020 and held it in 4 quarters.
HighTower Advisors's ENvue Medical Inc position peaked at $94K in Q1 2021.
15 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q3 2021.

Based on HighTower Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.